These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9663925)

  • 1. Synergistic effects of combined converting enzyme inhibition and angiotensin II antagonism on blood pressure in conscious telemetered spontaneously hypertensive rats.
    Webb RL; Navarrete AE; Davis S; de Gasparo M
    J Hypertens; 1998 Jun; 16(6):843-52. PubMed ID: 9663925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of valsartan and hydrochlorothiazide alone and in combination on blood pressure and heart rate in conscious-telemetered spontaneously hypertensive rats (SHR).
    Webb RL; Navarrete AE; Davis S
    Am J Hypertens; 1998 Jan; 11(1 Pt 1):59-65. PubMed ID: 9504451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats.
    Wood JM; Schnell CR; Cumin F; Menard J; Webb RL
    J Hypertens; 2005 Feb; 23(2):417-26. PubMed ID: 15662231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved glucose metabolism following blockade of angiotensin converting enzyme but not angiotensin AT1 receptors.
    Chow L; De Gasparo M; Levens N
    Eur J Pharmacol; 1995 Aug; 282(1-3):77-86. PubMed ID: 7498292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure.
    Jorde UP; Ennezat PV; Lisker J; Suryadevara V; Infeld J; Cukon S; Hammer A; Sonnenblick EH; Le Jemtel TH
    Circulation; 2000 Feb; 101(8):844-6. PubMed ID: 10694521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of valsartan and benazeprilat in salt-loaded stroke-prone spontaneously hypertensive rats.
    Webb RL; Barclay BW; Navarrete AE; Wosu NJ; Sahota P
    Clin Exp Hypertens; 1998 Oct; 20(7):775-93. PubMed ID: 9764721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of angiotensin converting enzyme but not of angiotensin AT1 receptors improves glucose tolerance.
    Chow L; De Gasparo M; Levens N
    Eur J Pharmacol; 1997 Jan; 319(1):77-83. PubMed ID: 9030901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
    Paull JR; Widdop RE
    J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prolonged blockade of the renin angiotensin system on striated muscle microcirculation of spontaneously hypertensive rats.
    Scheidegger KJ; Wood JM; van Essen H; Struijker-Boudier HA
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1276-81. PubMed ID: 8819512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple vasopeptidase inhibition of angiotensin-converting enzyme/neutral endopeptidase/endothelin-converting enzyme activities on the hemodynamic profile of chronically instrumented unrestrained conscious spontaneously hypertensive rats.
    Daull P; Blouin A; Sirois P; Nantel F; Jeng AY; Battistini B
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S398-401. PubMed ID: 15838331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade.
    Hulthén UL; Cao Z; Rumble JR; Cooper ME; Johnston CI
    Am J Hypertens; 1996 Sep; 9(9):895-901. PubMed ID: 8879346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems.
    Spinale FG; de Gasparo M; Whitebread S; Hebbar L; Clair MJ; Melton DM; Krombach RS; Mukherjee R; Iannini JP; O SJ
    Circulation; 1997 Oct; 96(7):2385-96. PubMed ID: 9337215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-over study comparing effects of treatment with an angiotensin converting enzyme inhibitor and an angiotensin II type 1 receptor antagonist on cardiovascular changes in hypertension.
    Gillies LK; Werstiuk ES; Lee RM
    J Hypertens; 1998 Apr; 16(4):477-86. PubMed ID: 9797193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
    Lassila M; Finckenberg P; Pere AK; Krogerus L; Ahonen J; Vapaatalo H; Nurminen ML
    Br J Pharmacol; 2000 Jul; 130(6):1339-47. PubMed ID: 10903974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of non-hypotensive doses of valsartan and enalapril improves survival of spontaneously hypertensive rats with endothelial dysfunction.
    de Gasparo M; Hess P; Nuesslein-Hildesheim B; Bruneval P; Clozel JP
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):151-8. PubMed ID: 11967807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of combination of valsartan with benazepril on blood pressure and left ventricular hypertrophy in SHR.
    Ke YS; Cao H; Yang T
    Acta Pharmacol Sin; 2000 Nov; 21(11):1043-7. PubMed ID: 11501062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of amlodipine and benazeprilat in spontaneously hypertensive rats.
    Bazil MK; Webb RL
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):405-11. PubMed ID: 7681501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of vascular angiotensin-converting enzyme by telmisartan via the peroxisome proliferator-activated receptor gamma agonistic property in rats.
    Takai S; Jin D; Kimura M; Kirimura K; Sakonjo H; Tanaka K; Miyazaki M
    Hypertens Res; 2007 Dec; 30(12):1231-7. PubMed ID: 18344629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive hypotensive effect of angiotensin-converting enzyme inhibition and angiotensin-receptor antagonism in essential hypertension.
    Stergiou GS; Skeva II; Baibas NM; Roussias LG; Kalkana CB; Achimastos AD; Mountokalakis TD
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):937-41. PubMed ID: 10836730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural adaptation to ischemia in skeletal muscle: effects of blockers of the renin-angiotensin system.
    Scheidegger KJ; Nelissen-Vrancken MH; Leenders PJ; Daemen MJ; Smits JF; Wood JM
    J Hypertens; 1997 Dec; 15(12 Pt 1):1455-62. PubMed ID: 9431852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.